Jian Min Fang
Vorstandsvorsitzender bei REMEGEN CO., LTD.
Vermögen: 87 Mio $ am 30.04.2024
Aktive Positionen von Jian Min Fang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| REMEGEN CO., LTD. | Direktor/Vorstandsmitglied | 04.07.2008 | - |
| Vorstandsvorsitzender | 04.07.2008 | - | |
| Technik-/Wissenschafts-/F&E-Leiter | 04.07.2008 | - | |
| Gründer | 04.07.2008 | - | |
MabPlex International Co., Ltd.
 MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Gründer | 25.06.2013 | - |
| Vorsitzender | 25.06.2013 | - | |
| Vorstandsvorsitzender | 25.06.2013 | 01.03.2020 | |
| Remegen Medical Research Shanghai Co. Ltd. | Direktor/Vorstandsmitglied | - | - |
| Remegen Biosciences, Inc. | Direktor/Vorstandsmitglied | - | - |
| Remegen Hong Kong Ltd. | Direktor/Vorstandsmitglied | - | - |
| Chinese Pharmaceutical Association | Direktor/Vorstandsmitglied | - | - |
| China Medicinal Biotech Association | Corporate Officer/Principal | - | - |
Karriereverlauf von Jian Min Fang
Ausbildung von Jian Min Fang
| Dalhousie University | Doctorate Degree |
Statistik
International
| China | 6 |
| Kanada | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 5 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| REMEGEN CO., LTD. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
| Chinese Pharmaceutical Association | |
| China Medicinal Biotech Association | |
MabPlex International Co., Ltd.
MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Health Technology |
| Remegen Medical Research Shanghai Co. Ltd. | |
| Remegen Biosciences, Inc. | |
| Remegen Hong Kong Ltd. |
- Börse
- Insiders
- Jian Min Fang
- Erfahrung
